Skip to main content
OpenTrials
Completed

NCT Number: NCT07419763

Intra Oral Appliance (IOA) Model Evaluating the Efficacy of Sensitive Toothpaste

This single-center, randomized, double-blind, three-period crossover in situ study evaluated the enamel remineralization potential and fluoride bioavailability of three dentifrices: a fluoride-free negative control, a positive control with 0.243% sodium fluoride, and an investigational dentifrice containing 0.243% sodium fluoride, 5.0% potassium nitrate (KNO₃), and 20% sodium bicarbonate. Adult subjects wore acrylic palatal appliances containing demineralized enamel specimens for three 7-day treatment periods, each preceded by a 5-day fluoride-free washout. Primary outcomes were percent surface microhardness recovery (%SMHR) and enamel fluoride concentration.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Therametric Technologies, Inc.

Noblesville, Indiana, 46060, United States

About this study

This in situ intraoral appliance (IOA) model evaluates anticaries potential by exposing demineralized enamel specimens to oral conditions while allowing for ex vivo treatment assessments. Subjects wore acrylic palatal appliances containing four enamel specimens covered with steel gauze to promote plaque formation. Each of the three treatment periods lasted seven days and included twice-daily toothbrushing and dentifrice slurry swishing, plus three daily sucrose challenges. A minimum 5-day fluoride-free washout preceded each period. Post-treatment specimens were analyzed for %SMHR and enamel fluoride concentration.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults ≥18 years
  • Good general and oral health
  • Normal unstimulated saliva flow (≥1.5 mL unstimulated saliva in 5 minutes)
  • ≥16 teeth and functional maxillary dentition to support palatal appliance
  • Agree to abstain from other oral care products and preventive dental procedures during study
  • No advanced periodontal disease, no visible untreated caries
  • If female, not pregnant or breastfeeding (self-reported)
  • No significant oral soft tissue pathology; no peri/oral piercings; no removable partial dentures
  • No antibiotics or immunosuppressives within 30 days of screening
  • No palatal torus; no medical condition that would interfere with safety
  • No allergy or significant adverse events to impression materials, acrylics, or common oral product

Exclusion criteria

  • Unable to tolerate appliance or comply with procedures
  • Oral pathology that interferes with participation
  • Use of fluoride toothpaste during washout periods
  • Participation in another appliance study within the last 4 week

Treatment and study plan

Negative Control Toothpaste

Drug

Fluoride-free toothpaste

Active Comparator

Drug

Commercially available fluoride toothpaste

test toothpaste

Drug

Investigational fluoride toothpaste

Primary outcomes

  1. Percent Surface Microhardness Recovery (%SMHR)

    Time frame: End of each 7-day test period (three periods total)

  2. Enamel Fluoride Concentration (EFU)

    Time frame: End of each 7-day test period (three periods total)

    Post-treatment enamel fluoride concentration (µg F/cm³)

Sponsors and collaborators

Lead sponsor

Church & Dwight Company, Inc.

Industry

Registry information

Official study title

Intra Oral Appliance (IOA) Model Evaluating the Efficacy of Three Dentifrices on Enamel Lesion Remineralization

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Feb 19, 2026
Registry last updated
Feb 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.